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Extracts obtained from seven tree species used in Sudanese traditional medicine were screened for antibacterial, anti-cholinesterase activities
and investigated for potential mutagenic effects using the Ames test. Antibacterial activity was detected using the micro-dilution assay. The extracts
were tested against Gram-positive: Bacillus subtilis and Staphylococcus aureus and Gram-negative: Escherichia coli and Klebsiella pneumoniae. Of
the plant extracts investigated, 75% showed minimum inhibitory concentration (MIC) values less than/or around 1.5 mg/ml. Extracts obtained from
Acacia seyal (ethanolic leaf extract) and Combretum hartmannianum (ethanolic leaf and root extracts), inhibited bacterial growth of both Gram-
positive and Gram-negative bacteria at a concentration less than/or around 0.39 mg/ml. The lowest MIC value (less than/or around 0.1 mg/ml) was
observed with the ethanolic (leaf, bark and root) and dichloromethane (bark) extracts of A. seyal, dichloromethane root extract of Capparis decidua,
ethyl acetate (bark and root) and ethanolic (root) extracts of Erythrina latissima against Gram-negative bacteria Klebsiella pneumoniae. In the
acetylcholinesterase inhibitory test, 58% of the plant extracts were active at a concentration of/or below 1 mg/ml using the micro-dilution assay. The
lowest IC50 value was 0.09 mg/ml observed with the ethanolic bark and root extracts of E. latissima and Kigelia africana. No potential mutagenic
effects was shown by the investigated plant extracts in the Ames assay.
© 2007 SAAB. Published by Elsevier B.V. All rights reserved.Keywords: Acetylcholinesterase inhibitory activity; Antibacterial activity; Genotoxicity1. Introduction
Plants continue to play a major role as therapeutic remedies
in primary health care in developing countries (Tshikalange
et al., 2005). Sudan is situated in tropical Africa and has
remarkable plant diversity and a cosmopolitan population. As
with other developing countries, traditional medicine plays a
major role especially in rural areas due to both economic and
cultural factors (Ali et al., 2002). Information about Sudanese
folk medicine was documented during comprehensive ethno-
botanical investigations by El Ghazali et al. (1994, 1997), and
El Kamali and El Khalifa (1999).Abbreviations: AChE, acetylcholinesterase; ATCI, acetylthiocholine iodide;
BSA, bovine serum albumin; DTNB, 5,5-dithiobis-2-nitrobenzoic acid; INT,
iodonitrotetrazolium violet; MH, Mueller–Hinton agar; MIC, minimum
inhibitory concentration; TLC, thin layer chromatography.
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doi:10.1016/j.sajb.2007.03.009There is an increasing number of diseases, including
bacterial infections which are exhibiting various levels of
drug resistance. The clinical efficacy of many existing
antibiotics is being threatened by the emergence of multidrug-
resistant pathogens (Eldeen et al., 2005). Higher plant extracts
lend themselves for medicinal applications due to the ability of
plants to produce compounds which confer antimicrobial
defenses against microbes in their own environment. This
ecological rationale justifies potential exploitation of this
resource for new therapeutic agents (Gibbons, 2003).
Acetylcholine is an organic molecule liberated at nerve
endings as a neurotransmitter. Neurotransmitter disturbances
and insufficient cholinergic functions are identified among the
pathological features in central nervous system disorders. The
most important changes observed in the brain are a decrease in
cortical levels of the neurotransmitter acetylcholine and
associated enzyme choline transferase. Inhibition of acetylcho-
linesterase therefore can restore the level of acetylcholine
(Greenblatt et al., 1999; Personeni et al., 2001; López et al.,ts reserved.
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traditionally to enhance cognitive function and to alleviate other
symptoms associated with Alzheimer's disease (Howes and
Houghton, 2003).
Chemicals that produce DNA damage leading to mutations or
cancer are described as genotoxic. Plants commonly used in
traditional medicine are assumed to be safe based on their long
usage in the treatment of diseases according to knowledge
accumulated over centuries. However, recent research has
shown some substances present in these medicinal plants to be
potentially toxic and carcinogenic (Fennell et al., 2004). It is
therefore important to investigate potential mutagenic effects in
order to validate safety for the continued use of medicinal plants.
In this study, extracts from seven tree species used in
Sudanese folk medicine were screened for antibacterial and
anti-cholinesterase activities and investigated for their potential
mutagenic effects.
2. Materials and methods
2.1. Plant material
Selection of the tree species investigated in this study was
based on their uses in Sudanese traditional medicine (Table 1).
Plant materials (leaves and/or twigs, roots, bark) were collected
from Shambat, Khartoum north-Sudan in December 2005. The
plants were authenticated at the Department of Silviculture,
Faculty of Forestry University of Khartoum, Sudan and voucher
specimens deposited in the Herbarium (Table 1).
The collected materials were dried, powdered and extracted
sequentially using dichloromethane, ethyl acetate and ethanol
(10 mg/ml) by sonication for 1 h. The extracts were filteredTable 1
Botanical name, family, voucher specimen and traditional uses of tree species used
Plant name Family Voucher
specimen
Traditional uses in Sudan an
Acacia seyal Del. Mimosaceae Ibra 1 Smoke of the wood is used
used for inflammation and s
Balanites aegyptiaca
(L.) Del.
Balanitaceae Ibra 2 Bark is used for venereal d
bilharzias in Sudan. The bark
body and as an abortifacient.
useful for other household an
Capparis decidua
(Forssk.) Edgew.
Capparidaceae Ibra 3 Fresh twigs are used for jau
Sudan for stomach disorders
Combretum
hartmannianum
Schweinf.
Combretaceae Ibra 4 Smoke of the bark and wood
used as an ingredient of a m
diseases and as an anthelmint
Erythrina latissima E.
Mey.
Papilionaceae Ibra 5 Bark is used as a purgative a
and throat inflammation in S
Iwu (1993), Hutchings et al.
Kigelia africana (Lam.)
Benth.
Bignoniaceae Ibra 6 Bark is used for stomach pro
is used for cough, dysentery
(1996), El Ghazali et al. (19
Ziziphus spina-christi
(L.) Willd.
Rhamnaceae Ibra 7 In Zambia, leaf preparations
dry hair. Fruits are used for s
used for chest pain, while ro
Roots are used for psychiatr
gastric infections, diarrhea, v
(1996), El Ghazali et al. (19using Whatman No. 1 filter paper and dried under a fan at room
temperature.
2.2. Micro-dilution antibacterial assay
The serial dilution technique described by Eloff (1998),
using 96-well micro-plates was used to determine the minimum
inhibitory concentration (MIC) of extracts for antibacterial
activity. Two ml cultures of four bacterial strains: Gram-
positive: Bacillus subtilis (ATCC No. 6051) and Staphylococ-
cus aureus (ATCC No. 12600) and two Gram-negative bacteria:
Escherichia coli (ATCC No. 11775) and Klebsiella pneumoniae
(ATCC No. 13883) were prepared and placed in a water bath
overnight at 37 °C. The overnight-cultures were diluted with
sterile MH broth (1 ml bacteria/50 ml MH). The extracts were
resuspended using ethanol to a concentration of 50 mg/ml. For
each of the four bacteria used, 100 μl of redissolved extract were
two-fold serially diluted with 100 μl sterile distilled water in a
96-well micro-plate. A similar two-fold serial dilution of
neomycin (Sigma) (0.1 mg/ml) was used as a positive control
against each bacterium. One hundred μl of each bacterial culture
were added to each well. The plates were covered and incubated
overnight at 37 °C. To indicate bacterial growth, 50 μl of
0.2 mg/ml p-iodonitrotetrazolium violet (INT) was added to
each well and the plates incubated at 37 °C for 30 min. Bacterial
growth in the wells was indicated by a red colour, whereas clear
wells indicated inhibition by the tested substances.
2.3. Acetylcholinesterase enzyme inhibitory activity
Inhibition of acetylcholinesterase biosynthesis by plant extracts
was investigated using thin layer chromatography (TLC) andin Sudanese traditional medicine
d other African countries
for treatment of arthritis rheumatism and rheumatic fever in Sudan. Leaves are
tomach disorders El Ghazali et al. (1997).
iseases and rheumatism. Fruits are used for digestion problems, dysentery and
is reported to be applied in the form of cutaneous implantations to strengthen the
The tree features prominently in Hausa ethnomedicine and has been found most
d for religious rituals Iwu (1993), El Ghazali et al. (1997), VanWyk et al. (1997).
ndice, rheumatic arthritis and to treat swells. Different plant parts are used in
El Ghazali et al. (1997).
is used for arthritis rheumatism and to treat dryness of skin in Sudan. Leaves are
edication for jaundice. Various members of the genus are employed for bacterial
ic in many parts of Africa Iwu (1993), Neuwinger (1996), El Ghazali et al. (1997).
nd for the treatment of bronchial infections, coughs, wounds, abscesses, arthritis
udan. In Nigeria, aqueous extract of the bark is used for the treatment of jaundice
(1996), Van Wyk et al. (1997).
blems and bilharzias. In Sudan, Nigeria, Senegal, Ghana, Benin and Kenya, bark
and venereal diseases. A decoction of the leaves is drunk for jaundice Neuwinger
97).
are used for ulcers and gonorrhea. Leaves are used to slow balding and also for
ore throat. The tree is also reputable from a religion perspective in Sudan. Bark is
ot infusion is administered for dysentery in Sudan and some African countries.
ic medicine in Sudan and Mali. Hausa in Niger used the roots and the leaves for
enereal diseases, wounds, chest pain, constipation and nervousness Neuwinger
97), Dafni et al. (2005).
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(Ellman et al., 1961) with modifications. The enzyme activity is
measured by observing the increase of a yellow colour produced
from thiocholine when it reacts with the dithiobisnitrobenzoate
ion. Acetylthiocholine iodide (ATCl), acetylcholinesterase
(AChE), from electric eels (type VI-S lypophilized powder),
5,5-dithiobis-2-nitrobenzoic acid (DTNB), and galanthamine
were obtained from Sigma-Aldrich. The following buffers were
used; Buffer A:50 mM Tris–HCl, pH 8; Buffer B: 50 mM Tris–
HCl, pH 8 containing 0.1% bovine serum albumin (BSA); Buffer
C:50 mM Tris–HCl, pH 8, containing 0.1 M NaCl and 0.02 M
MgCl2·6H2O.
For the TLC assay, 10 μl plant extract and 5 μl 0.2 mM
galanthamine hydrobromide were spotted on TLC plates and
developed in chloroform:methanol (8:2). The TLC plate was
sprayed with 5 mM ATCl and 5 mM DTNB in 50 mM Tris–
HCl, pH 8 until the silica was saturated with the solvent.
Enzyme inhibitory activity of the plant extracts was detected by
spraying the TLC plate with substrate (1 mM ATCl in buffer A),
dye (1 mM DTNB in buffer A) and enzyme (3 U/ml AChE in
buffer A). After 2–5 min a yellow background appeared with
white spots for AChE inhibiting compounds. These were
observed and recorded within 5 min. False-positive reactions
were eliminated by mixing enzyme with the substrate before
spraying onto the TLC plate.
The microplate assay utilised an Opsys MR 96-well
microplate reader. In the 96-well plates, 25 μl of 15 mM
ATCl in water, 125 μl of 3 mM DTNB in buffer C, 50 μl of
buffer B and 25 μl of sample were added. The absorbance was
measured at 405 nm every 45 s (five times). Then 25 μl of
0.2 U/ml of enzyme were added, the absorbance was measured
again every 45 s (eight times). The rate of reaction was
calculated. Any increase in absorbance due to the spontaneousTable 2
Antibacterial activity (MIC) of plant extracts obtained from trees used in Sudanese
Plant species Plant
part
analyzed
Dichloromethane extract
Bacteria tested
B. s S. a E. c K. p
Acacia seyal Leaf 0.39 1.5 1.5 0.39
Bark 078 1.56 1.56 b0.1
Root 3.13 3.13 3.13 0.78
Balanites aegyptiaca Leaf 3.13 3.13 3.13 0.78
Bark 0.78 3.13 3.13 0.39
Root 0.78 3.13 3.13 0.39
Capparis decidua Twigs 3.13 1.56 1.56 0.78
Root 1.56 1.56 1.56 b0.1
Combretum hartmannianum Leaf b0.1 1.56 1.56 0.2
Bark 3.13 3.13 3.13 0.39
Root 0.1 3.13 3.13 0.78
Erythrina latissima Bark b0.1 1.56 1.56 b0.1
Root 6.25 3.13 3.13 6.25
Kigelia africana Leaf 1.56 3.13 1.56 1.56
Bark 0.39 1.56 0.78 0.78
Ziziphus spina-christi Leaf 3.13 1.56 3.13 1.56
Bark 3.13 6.25 6.25 3.13
Neomycin (μg/ml) Bs:1.9×10−1 Sa: 7.8×10−1
Values given are in mg/ml.
Bacteria: B. s = Bacillus subtilis; E. c = Escherichia coli; K. p = Klebsiella pneumohydrolysis of the substrate was corrected by subtracting the ratio
of reaction before adding the enzyme from the rate after adding
the enzyme. Percentage of inhibition was calculated by
comparing the reaction rates for the sample to the blank
(methanol in buffer A).
2.4. Genotoxicity test
The potential mutagenic effects of the investigated plants
were determined using the Ames test. The Ames assay was
performed with Salmonella typhimurium (strain TA98) using
the plate incorporation procedure described byMaron and Ames
(1983). One hundred μl of bacterial stock were incubated in
20 ml of Oxoid Nutrient for 16 h at 37 °C on an orbital shaker.
The overnight culture (0.1 ml) was added to 2 ml top agar
(containing traces of biotin and histidine) together with 0.1 ml
test solution (plant extract, solvent control or positive control)
and 0.5 ml phosphate buffer (for exposure without metabolic
activation). The top agar mixture was poured over the surface of
the agar plate and incubated for 48 h at 37 °C. After incubation,
the number of revertant colonies (mutants) were counted. All
cultures were made in triplicate (except the solvent control
where five replicates were made) for each assay. The assays were
repeated twice. The positive control used was 4-nitroquinoline
1-oxide (4-NQO) at a concentration of 2 μg/ml.
3. Results and discussion
3.1. Antibacterial activity
TheMIC values of the plant extracts obtained using the micro-
dilution assay are shown in Table 2. Of the plant extracts tested,
75% showed MIC values less than/or around 1.5 mg/ml. Thetraditional medicine as determined by the micro-dilution assay
Ethyl acetate Ethanol extract
Bacteria tested Bacteria tested
B. s S. a E. c K. p B. s S. a E. c K. p
0.39 1.56 0.78 0.2 0.2 0.39 0.39 b0.1
3.13 3.13 6.25 1.56 0.39 0.36 1.56 b0.1
1.56 3.13 3.13 0.78 b0.1 1.56 1.56 b0.1
3.13 1.56 3.13 0.39 3.13 3.13 3.13 0.78
0.78 3.13 3.13 3.13 6.25 3.13 3.13 12.5
0.39 3.13 3.13 0.2 6.25 3.13 3.13 12.5
3.13 3.13 3.13 0.78 6.25 3.13 3.13 1.56
1.56 1.56 1.56 0.78 3.13 3.13 3.13 1.56
0.39 1.56 1.56 0.78 0.2 0.2 0.39 0.39
0.39 3.13 3.13 0.78 1.56 3.13 1.56 0.78
0.39 3.13 3.13 0.78 0.39 0.2 0.2 0.2
1.56 1.56 1.56 b0.1 b0.1 0.39 0.39 0.2
1.56 1.56 1.56 b0.1 1.56 1.56 1.56 b0.1
0.2 1.56 0.78 0.2 0.78 1.56 1.56 1.56
0.1 1.56 0.78 0.78 6.25 6.25 6.25 6.25
0.2 1.56 1.56 0.2 1.56 3.13 3.13 1.56
1.56 1.56 1.56 1.56 0.39 1.56 1.56 0.78
Ec: 6.25 Kp: 1.56
niae; S. a = Staphylococcus aureus.
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hartmannianum (ethanolic extracts), inhibited growth of both
Gram-positive and Gram-negative bacteria at a concentration less
than/or around 0.39 mg/ml. The ethanolic (leaf, bark, root) and
dichloromethane (bark) extracts ofA. seyal, dichloromethane root
extract of Capparis decidua, ethyl acetate (bark and root) and
ethanolic (root) extracts of Erythrina latissima inhibited growth
of Gram-negative bacteria Klebsiella pneumoniae at a concen-
tration less than/or around 0.1 mg/ml while the ethanolic root
extracts of C. hartmannianum inhibited growth of E. coli with an
MIC value of 0.2 mg/ml.
Different parts of the investigated plants are administered in
Sudanese traditional medicine for the treatment of various
ailments including microbial infections. Bacteria species such
as E. coli, S. aureus, Bacillus and Klebsiella species possess
potent enterotoxins. It can be life-threatening during gastroen-
teritis infections (Lewis and Elvin-Lewis, 2003).
Previous work from our laboratory showed high levels of
antibacterial activities of extracts obtained from Acacia nilotica
and A. sieberiana (Eldeen et al., 2005). The previously reported
biologically activity of Acacia species was attributed to the
presence of some bioactive agents such as ethyl galate and the
flavonoids, octasanol, β-amyrin and α-betulin (Ayoub, 1984;
Abdelnabi et al., 1992; Neuwinger, 1996). Not much informa-
tion is available about the biological activity of A. seyal. The
activity shown by the species may well be due to the presence of
similar compounds.
Several bioactive compounds such as the drug ‘kinkeliba”
(isolated from leaves of C. micranthum), stilbenes, hydro-
xystilbenes and acidic triterpenoids amongst many others are
present in Combretum species (Iwu, 1993; Bruneton, 1995;
Hutchings et al., 1996; Rogers and Verotta, 1996; McGaw et al.,
2000). While little pharmacological data is available for C.
hartmannianum, the high antibacterial activity shown by theTable 3
Inhibition of acetylcholinesterase activity by plant extracts (1 mg/ml) obtained from tr
Plant species Plant
part
analyzed
Inhibition (%) and IC50 values (mg/m
Plant extracts tested at concentration o
Dichloro-methane IC50 Ethyl a
Acacia seyal Leaf 55 0.37 77
Bark 89 0.18 40
Root 50 1.0 56
Balanites aegyptiaca Leaf 47 – 47
Bark 48 – 22
Root 48 – 13
Capparis decidua Twigs 67 0.37 55
Root 70 0.37 50
Combretum hartmannianum Leaf 6 – 33
Bark 50 1.0 45
Root 44 – 11
Erythrina latissima Bark 50 1.0 20
Root 27 – 22
Kigelia africana Leaf 22 66
Bark 56 0.5 75
Ziziphus spina-christi Leaf 53 0.76 56
Bark 57 0.78 50
Results given are percentage inhibition and IC50 values.
Inhibition (%) of acetylcholinesterase enzyme by galanthamine (20 μM) was 90% wplant extracts in this study is interesting and may well be
attributed to the presence of similar or related bioactive
constituents.
The relatively weak antibacterial activities (with some
exceptions) showed by some extracts obtained from Balanites
aegyptiaca, C. decidua and Ziziphus spina-christi does not
necessarily mean absence of bioactive constituents. Active
compound(s) may be present in insufficient quantities in the
crude extracts to show activity with the dose levels employed.
Lack of activity can thus only be proven by using large doses.
Extracts may also be active against other bacterial species which
were not tested. (Farnsworth, 1993; Jäger et al., 1996; Shale
et al., 1999; Taylor et al., 2001).
The leaf and bark of Kigelia africana showed antibacterial
activity against both Gram-positive and Gram-negative bacte-
ria. This supports previous findings of Kwo and Craker (1996).
These results may justify the intensive use of this tree in
traditional medicine throughout its distribution range (Retief
and Herman, 1997).
The low MIC values detected by some of the investigated
plant extracts against both Gram-positive and Gram-negative
bacteria (less than/or around 0.39 mg/ml) give an indication of
the presence of promising antibacterial compounds which need
to be isolated and identified.
3.2. Acetylcholinesterase enzyme inhibitory activity
Results of acetylcholinesterase enzyme inhibitory activity of
the tested plant extracts are shown in Table 3. A minimum
inhibition of 50% is required for the tested plant extracts to be
considered active. Based on this criterion, 58% of the extracts
showed activity against the acetylcholinesterase enzyme in the
TLC and micro-dilution assays. At a concentration of 1 mg/ml,
dichloromethane (bark) and ethanolic (leaf and bark) extracts ofees used in Sudanese traditional medicine as determined by the micro-plate assay
l)
f 1 mg/ml
cetate IC 50 Ethanol IC50 Galanthamine (20 μM) IC50 (μM)
0.37 92 0.37 90 2.0
– 90 0.37
0.37 56 0.76
– 42 –
– 40 –
– 24 –
0.76 42 –
1.0 44 –
– 79 0.25
– 66 0.37
– 71 0.37
– 68 0.187
– 91 0.093
0.76 78 0.25
0.37 87 0.09
0.37 67 0.37
1.0 74 0.37
ith an IC50 value of 2.0 μM.
439I.M.S. Eldeen, J. Van Staden / South African Journal of Botany 73 (2007) 435–440A. seyal, ethanolic root extract of E. latissima and ethanolic bark
extract ofK. africana showed the highest level of activity (N85%)
against the acetylcholinesterase enzyme. The range of IC50 value
was 0.3 to 0.09 mg/ml. Moderate activities (b60%) were
observed with the dichloromethane (leaf) and all extracts from
the root of A. seyal, dichloromethane bark extract of C.
hartmannianum, E. latissima, K. africana and both dichloro-
methane and ethyl acetate (leaf and bark) extracts of Z. spina-
christi (range of IC50 value was 1.0–0.3 mg/ml). The lowest IC50
value was observed with the ethanolic bark and root extracts of E.
latissima andK. africana (0.09mg/ml). The percentage inhibition
of galanthamine (positive control) at a concentration of 20 μM
was 90% and the IC50 value was 2 μM. This was comparable to a
previous report in the literature where 1.9 μM was recorded
(Elgorashi et al., 2004).
With the exception of twigs and roots of C. decidua and
roots of A. seyal, ethanolic extracts exhibited strong activity
when compared to ethyl acetate and dichloromethane extracts.
The plant extracts that possessed activity against acetylcho-
linesterase in this study were reported to contain different types
of alkaloids. Alkaloids are known to exhibit a number of
pharmacological properties, amongst them inhibition of acet-
ylcholineseterase enzyme activity. Combretum species are
reported to have saponaretine and quaternary amino bases
comprising two major alkaloids, combretines A and B,
stereoisomers of betonicine (Iwu, 1993; Bruneton, 1995).
E. latissima was reported to produce ery-thrina-type alkaloids
such as (+)-ery-thraline, (+)-11-hydroxyerysodine, (+)-erythra-
tidine and (+)-erysosalvine (Majinda et al., 2001). The presence
of alkaloids and/or other similar compounds might explain the
inhibition of acetylcholinesterase activity observed by the plant
extracts.
Z. spina-christi is a “Holy” tree in Arab and Middle eastern
cultures. It has been used traditionally for treatments of various
ailments related to central nervous system disfunction (Iwu,
1993; Dafni et al., 2005). The present findings support such
usage in the traditional remedies.
In general, leaf extracts of some of the investigated plants
showed different levels of biological activities compared to the
other plant parts (A. seyal, C. hartmannianum, E. latissima and
K. africana). Presence of such activities in the leaf extracts
implies that there could be possibilities of substituting leaves for
roots and bark while utilising the particular plant species (Matu
and Van Staden, 2003).
3.3. Mutagenic effects
In the mutagenicity testing of different plant parts using the
Salmonella strain (TA98), results are based on the number of
induced revertant colonies. Plant extracts were considered
active if the number of the induced revertant colonies was
double the revertant colonies of the blank (negative control).
None of the investigated plants showed any potential mutagenic
effects.
Although no potential mutagenic effects have been shown by
the plants in this study, this does not necessarily mean absence
of adverse effects that justifies their use as a safe traditionalmedicine. Due to complexity of mutation mechanisms, accurate
evaluation of mutagenic activity of medicinal plants using
developed and sophisticated tools are needed (Debnath et al.,
1991).
Generally, the results obtained in this study are in line with
the traditional uses of the plants as crude antibacterial drugs.
However, traditional healers seldom use a single plant in their
extracts. In many cases the therapeutic benefits are attributed to
the consumption of plant mixtures in which different plant parts
are prepared and/or consumed in combination or in sequence
(Etikin, 1986; Taylor et al., 2001).
There is not much detailed documentation on the pharmaco-
logical properties of Sudanese medicinal plants. Such studies
therefore can contribute positively towards the formulation of
traditional knowledge by providing a scientific basis with
respect to raw materials and methods of production. It would
also enable local knowledge of medicinal plants to be compiled
and conserved (Anand andNityanand, 1984; Taylor et al., 2001).
The results obtained from this study strongly support further
investigation into pharmacological properties of secondary
metabolites of higher plants as a promising source of bioactive
compounds (Balandrin et al., 1993; Lewis and Elvin-Lewis,
2003). Higher plants represent an extraordinary reservoir based
on the fact that trees resist attack by fungi and/or other
organisms by producing antimicrobial agents in their wood,
bark and leaves. It is reasonable then to assume that these
bioactive compounds may also be inhibitory to closely related
human pathogens (Lewis and Elvin-Lewis, 2003).
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